» Articles » PMID: 31984243

Neurocognitive and Functional Impairment in Adult and Paediatric Tuberculous Meningitis

Overview
Date 2020 Jan 28
PMID 31984243
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

In those who survive tuberculous meningitis (TBM), the long-term outcome is uncertain; individuals may suffer neurocognitive, functional and psychiatric impairment, which may significantly affect their ability to lead their lives as they did prior to their diagnosis of TBM. In children who survive, severe illness has occurred at a crucial timepoint in their development, which can lead to behavioural and cognitive delay. The extent and nature of this impairment is poorly understood, particularly in adults. This is in part due to a lack of observational studies in this area but also inconsistent inclusion of outcome measures which can quantify these deficits in clinical studies. This leads to a paucity of appropriate rehabilitative therapies available for these individuals and their caregivers, as well as burden at a socioeconomic level. In this review, we discuss what is known about neurocognitive impairment in TBM, draw on lessons learnt from other neurological infections and discuss currently available and emerging tools to evaluate function and cognition and their value in TBM. We make recommendations on which measures should be used at what timepoints to assess for impairment, with a view to optimising and standardising assessment of neurocognitive and functional impairment in TBM research.

Citing Articles

A historic case of relapsing-remitting Alzheimer's disease in an adolescent attributed to scarlet fever.

Lathe R, Balin B J Alzheimers Dis Rep. 2025; 9:25424823241298530.

PMID: 40034507 PMC: 11864263. DOI: 10.1177/25424823241298530.


Perspectives from the 2 International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomes.

Allwood B, Nightingale R, Agbota G, Auld S, Bisson G, Byrne A IJTLD Open. 2024; 1(3):111-123.

PMID: 38966406 PMC: 11221578. DOI: 10.5588/ijtldopen.23.0619.


Analysis of risk factors for long-term mortality in patients with stage II and III tuberculous meningitis.

Wang L, Gu Z, Chen X, Yu X, Meng X BMC Infect Dis. 2024; 24(1):656.

PMID: 38956526 PMC: 11218231. DOI: 10.1186/s12879-024-09561-0.


Evaluating cognitive outcomes in adult patients with acute encephalitis syndrome: a prospective study from a tertiary care center in Nepal.

Rayamajhi P, Nepal G, Ojha R, Rajbhandari R, Gajurel B, Karn R Encephalitis. 2023; 2(2):36-44.

PMID: 37469649 PMC: 10295914. DOI: 10.47936/encephalitis.2021.00157.


Post-TB health and wellbeing.

Nightingale R, Carlin F, Meghji J, McMullen K, Evans D, van der Zalm M Int J Tuberc Lung Dis. 2023; 27(4):248-283.

PMID: 37035971 PMC: 10094053. DOI: 10.5588/ijtld.22.0514.


References
1.
Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon K . The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Mov Disord. 2010; 25(3):401-4. DOI: 10.1002/mds.22748. View

2.
DASTUR D, Lalitha V, UDANI P, Parekh U . The brain and meninges in tuberculous meningitis-gross pathology in 100 cases and pathogenesis. Neurol India. 1970; 18(2):86-100. View

3.
Thomas M, Chopra J, Walia B . Tuberculous meningitis (T.B.M.)(a clinical study of 232 cases). J Assoc Physicians India. 1977; 25(9):633-9. View

4.
Grant I, Atkinson J, Hesselink J, Kennedy C, Richman D, Spector S . Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med. 1987; 107(6):828-36. DOI: 10.7326/0003-4819-107-6-828. View

5.
Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N . Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Int. 2010; 10(3):225-32. DOI: 10.1111/j.1447-0594.2010.00585.x. View